​

Opus Genetics (IRD) Revenue & Revenue Breakdown

OverviewForecastFinancialsChart

Opus Genetics Revenue Highlights

Latest Revenue (Y)

$10.99M

0

Opus Genetics Revenue by Period

Opus Genetics Revenue by Year

DateRevenueChange
2024-12-31$10.99M-42.30%
2023-12-31$19.05M-52.20%
2022-12-31$39.85M6665.70%
2021-12-31$589.00K100.00%
2020-12-31-100.00%
2019-12-31--

Opus Genetics generated $10.99M in revenue during NA 2024, up -42.30% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Opus Genetics Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$2.88M-34.05%
2025-03-31$4.37M1.58%
2024-12-31$4.30M11.25%
2024-09-30$3.87M247.75%
2024-06-30$1.11M-35.01%
2024-03-31$1.71M1.18%
2023-12-31$1.69M-85.83%
2023-09-30$11.94M224.85%
2023-06-30$3.67M110.06%
2023-03-31$1.75M-95.61%
2022-12-31$39.85M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$489.00K389.00%
2021-06-30$100.00K100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Opus Genetics generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Opus Genetics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AGENAgenus$103.46M$30.23M
ALECAlector$100.56M$3.26M
SEERSeer$14.17M$4.12M
IRDOpus Genetics$10.99M-
VTGNVistaGen Therapeutics$1.06M$244.00K
MCRBSeres Therapeutics-$351.00K
INOInovio Pharmaceuticals--
CGTXCognition Therapeutics--
ABOSAcumen Pharmaceuticals--
TILInstil Bio--
HURATuHURA Biosciences--

IRD Revenue FAQ

What is Opus Genetics’s yearly revenue?

Opus Genetics's yearly revenue for 2024 was $10.99M, representing a decrease of -42.30% compared to 2023. The company's yearly revenue for 2023 was $19.05M, representing a decrease of -52.20% compared to 2022. IRD's yearly revenue for 2022 was $39.85M, representing an increase of 6665.70% compared to 2021.

What is Opus Genetics’s quarterly revenue?

Opus Genetics's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $2.88M, a -34.05% decrease from the previous quarter (Q1 2025), and a 159.17% increase year-over-year (Q2 2024). IRD's quarterly revenue for Q1 2025 was $4.37M, a 1.58% increase from the previous quarter (Q4 2024), and a 155.41% increase year-over-year (Q1 2024).

What is Opus Genetics’s revenue growth rate?

Opus Genetics's revenue growth rate for the last 3 years (2022-2024) was -72.42%, and for the last 5 years (2020-2024) was 0%.